Digital Structuring the unstructured: Deterministic AI and white box... Speed and safety in drug development and discovery represent some of the biggest challenges and opportunities facing life sciences companies today.
Digital Artificial intelligence: The saviour of the pharmaceutical i... There is a lot, and I mean a lot, of discussion right now about the potential for artificial intelligence (AI) to transform the pharmaceutical industry (as, indeed, there is across all indu
Sales & Marketing Sponsored The next frontier: How to use AI-powered analytics for life ... Using spreadsheets for data analysis is totally okay, especially if we are talking about standardised small-to-medium datasets.
Digital Considering current legal risks from the use of AI in the li... The use of artificial intelligence (AI) in the life sciences sector is increasing, and its applications may be transformative.
Digital AI-powered computer vision accelerates innovation Few industries are as important to the wellbeing of people than those that produce the medical devices and drugs that enhance and save lives.
R&D Immune mediation, B-cell depletion, and female leadership – ... In a new pharmaphorum podcast, Aoife Brennan, CEO of Climb Bio, discusses the treatment of immune-mediated diseases.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face